Europe Vascular Guidewires Market

Europe Vascular Guidewires Market Size (2023 to 2028)

The Vascular Guidewires Market size in Europe is predicted to grow at a robust CAGR from 2023 to 2028.

Factors such as rising aging population, growing diagnostic procedures, never stopping R & D activities, and increasing demand for minimally invasive surgeries are majorly accelerating the European region's vascular guidewires market. Additionally, it has been noticed that the need for these medical products is significantly increasing from the last few years, which is further estimated to escalate the growth rate of the market.

High costs associated with the vascular guidewires and growing deductions from excise taxes are expected to stand as hurdles to the market growth to a small extent. The availability of substitute treatments may hamper the growth in this region.

This research report on the Europe vascular guidewires market has been segmented and sub-segmented into the following categories.

By Product:

• Coronary Guidewires
• Peripheral Guidewires

By Coating Type:

• Coated
  • Hydrophobic Coatings
  • Non-Hydrophobic Coatings
• Non-Coated

By End-User:

• Hospitals
• Ambulatory Surgical Centers

By Country:

• United Kingdom
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Rest of Europe

Based on geography, the Europe Vascular Guidewires Market is expected to exhibit high growth because of the focus on the R & D sector. Globally, the European market was the second largest in 2021 and predicted to hike at a healthy CAGR during the forecast period.

Germany was leading the European market in 2021 with the highest share among all the other nations due to increasing healthcare expenditure, well-organized, monetary healthcare system, and other facilities such as reimbursements surge the market growth.

The UK is next to Germany in accounting, promising growth in the European market. The existence of advanced technologies for certain chronic diseases is expected to favor the market in the United Kingdom. In France, the usage of these vascular guide wires devices is rapidly increasing, further boosting the market. Growing government projects and proposals for developing the healthcare infrastructure and educational programs brings out awareness in people regarding the cardiovascular diseases of the region to escalate the market.

Promising manufacturers operating in the Europe vascular guidewires market are Abbott Laboratories, Terumo Corporation, B. Braun Melsungen AG, Medtronic plc, Biotronik SE & Co. KG, Cook Medical, Inc., Boston Scientific Corporation, Cardinal Health, Inc., C. R. Bard, Inc., and The Spectranetics Corporation.